Terazosin capsules

Details Terazosin capsules Terazosin capsules

1999-05-18

2000-08-29

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424456, A61K 948

Patent

active

061104930

ABSTRACT:
A capsule dosage form containing solid form of terazosin in a solid carrier is disclosed. The capsule dosage form is stable under accelerated stability conditions and therapeutically equivalent to known liquid-filled terazosin capsules.

REFERENCES:
patent: 4092315 (1978-05-01), Biancee
patent: 4112097 (1978-09-01), Uinn et al.
patent: 4251532 (1981-02-01), Roteman
patent: 5122514 (1992-06-01), Boger et al.
patent: 5212176 (1993-05-01), Kymil et al.
patent: 5294615 (1994-03-01), Meyer et al.
patent: 5362730 (1994-11-01), Bauer et al.
patent: 5412095 (1995-05-01), Merley et al.
patent: 5504207 (1996-04-01), Mannine et al.
patent: 5587377 (1996-12-01), Patel et al.
patent: 5952003 (1999-09-01), Guentensberger et al.
patent: 5959108 (1999-09-01), Bauer et al.
Hytrin monograph P.D.R. 46th Ed. (1992) pp. 529-531.
Hytrin monograph, P.D.R. 50th Ed. (1996) pp. 430-433.
Merck Index, 11th Ed. (1989) entry 9084.
Information Obtained Under the Freedom of Information Act relating to NDA-057 (1988).
U.S. Pharmacopeial Convention, Inc., 23, p. 1791-1793 (1995).
Sucker, et al., Pharmazeutiside Technologie, p. 320-322, Thieme Verlag Stuttgart (1991).
Information obtained under The Freedom of Information Act relating to NDA 20-347 (Dec. 1994).

Affiliated with

Also associated with

Rating

Terazosin capsules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Terazosin capsules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Terazosin capsules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246934